Malaria Diagnostics Market Size, Share & Trend Report

Malaria Diagnostics Market Size, Share & Trend Analysis Report By Technology (Microscopy, Rapid Diagnostic Test, and Others), By Region, And Segment Forecasts, 2012 - 2022

  • Published Date: Feb, 2018
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-711-7
  • Format: Electronic (PDF)
  • Historical Data: 2012 - 2015
  • Number of Pages: 81

Industry Insights

The global malaria diagnostics market size was valued at USD 604.3 million in 2016 and is anticipated to witness a CAGR of 4.5% during the forecast period. Increasing demand for malaria diagnostics in malaria endemic countries and development of technologically advanced and efficient diagnostic tools are key factors propelling the growth of the market.

South Africa malaria diagnostics market

Malaria diagnosis involves the use of various techniques that include microscopy and blood tests to evaluate the presence of the infection causing protozoan in an individual. Techniques such as molecular diagnostics and rapid diagnostic tests are used primarily and ultimately microscopy is used to ascertain the presence of the disease causing parasite. The demand for advanced diagnostic tests has been seen lately, fueling the market growth of novel techniques that provide efficient results and prevent false positives.

According to the World Health Organization, more than 212 million cases of malaria were recorded in the year 2015 globally. Data from the same source indicate that the total funding for malaria control and elimination in the year 2015 was estimated to be around USD 2.9 billion. Spending on research and development for malaria was estimated to be around USD 611 million in the year 2014 increasing from USD 607 million in the year 2010. 

These facts are indicative of the rise in the malaria incidence globally. Since, the disease is preventable, increased efforts are being taken by governments to reduce the incidence of the disease especially among the developed and underdeveloped nations. Thus, the development of diagnostic tests that are economical, affordable and provide quick and efficient results was established as the key strategy undertaken by most governments.

However, precise diagnosis plays a vital role in malaria, the development of various diagnostic tests that are efficient and rapid has been seen in endemic nations. Increasing research and development being done by various developers in the market has been leading to new product launches that are easy to use and provide quick results. Since the disease is usually seen in areas that are tropical and remote, the development of tests that can be used for detection in such areas has been encouraged by governments across the globe.

Product Insights

Based on technology, the malaria diagnostics market is segmented into microscopy, rapid diagnostic tests and others. The other techniques that are used to diagnose malaria are PCR (Polymerase Chain Reaction) and RT-PCR (Real Time-Polymerase Chain Reaction). The highest market revenue in this segment was held by microscopy owing to its conventional usage in malaria detection. The highest CAGR was held by RDT as they are used for easy and effective detection of antigens in the patient’s blood and can be used in rural areas as well.

Microscopy is assumed to be a gold standard method in diagnosing malaria as it is one of the most conventional and reliable methods for the detection of malarial parasites in human blood. This method requires a trained professional and hence the application of microscopic diagnosis may be difficult in remote and under developed countries of the world. Typically, it is carried out in large hospitals and health centers for the detection purposes. Being the first choice as a diagnostic method, microscopy is estimated to account for the largest share in the malaria diagnostics market by technology.

Rapid diagnostic tests make use of a test card, where the blood sample is applied along with specific reagents, following the appearance of specific bands in the test card, the presence of infection with either of the human malarial parasites is seen. These RDTs are capable of detecting P. falciparum or any of the other three species of human malaria. The malarial RDTs are mainly used, where microscopy examination is not feasible, especially in remote areas with limited access to quality microscopy services or in areas that have poor healthcare infrastructure. However, malaria RDTs are qualitative tests and not quantitative and hence, the need for microscopic examination is not completely eliminated in these cases. In regions such as Africa that witness the highest disease burden and have limited access to medical facilities and hospitals, the use of RDTs provides an easy way of disease detection, propelling the growth of the market.

Other than microscopy and RDT, there are few molecular diagnostic technologies in the market, which aid in the diagnosis of malaria. These include Polymerase Chain Reaction (PCR) and Real Time-Polymerase Chain Reaction (RT-PCR). These tests are highly sensitive, accurate, and capable of detecting low parasite count. Malaria can also be diagnosed during routine blood tests using hematology analyzers and flow cytometry. However, the market share of these tests is less significant owing to its high cost and requirement of specialized laboratories and skilled workforce.

Regional Insights

The malaria diagnostics market is analyzed for Africa, Eastern Mediterranean, South-East Asia, Western Pacific, America, and Europe in this particular study. Africa is expected to dominate the market with a share of 68.1% in 2015, majorly owing to the highest disease burden. South-East Asian malaria diagnostic market is estimated to hold the second position in the market with India accounting for the largest share of the regional market. The European market, by value, is expected to hold the least share in 2015 owing to the increasing number of malaria-free countries in the region.

Global malaria diagnostics market

The African region contributed to the highest market share owing to predominance of including local weather conditions, poverty, high distribution of P. falciparum, socio-economic instability, and under developed healthcare systemamong others key factors. However, despite the highest burden of malaria, the region has witnessed significant decline in the malaria incidence and death rate. The key factor attributing to this upsurge is the increased use of rapid diagnostic testing. Thus, with various initiatives being undertaken by the government and health organizations, this region is expected to gain lucrative market share during the forecast period.

As of 2015, South-East Asia accounted for around 10% of the global malaria incidences, whereas the mortality rate was around 7% in the same year. The key country considered in the region is India, which is estimated to account for the largest number of malaria cases in the region. The malaria diagnostic testing, by volume, in India is majorly dominated by microscopy testing, attributing to the growth of the segment in the region. Since the region consists of developing nations, the demand for RDTs are seen in various nations contributing to their market revenue.

Malaria Diagnostics Market Share Insights

The malaria diagnostics market is highly fragmented. It comprises many local and few global players. The market is expected to consolidate around three market players at the global level. These include Alere Inc., Access Bio Inc., and Premier Medical Corporation Ltd. Product development, partnerships, and collaborations are the key strategies adopted by the company for sustainable growth.

Access Bio Inc. is expected to be one of the key players in the malaria diagnostics market in near future. The key product manufactured by the company is malaria Rapid Diagnostic Tests (RDTs), which accounted for around 93% of the company’s sales in 2014. The company serves governments in Europe, South-East Asia, Americas, Middle East, and Africa. The other companies with significant market shares in malaria RDT market include Tulip Group and ICT Diagnostics among others.

Report Scope



Base year for estimation


Actual estimates/Historical data

2012 - 2015

Forecast period

2016 - 2022

Market representation                                    

Revenue in USD Million and CAGR from 2015 to 2022

Regional scope

Africa, East Mediterranean, America, Europe, South-East Asia, and Western Pacific

Country scope

South Africa, Nigeria, India, Saudi Arabia, Turkey, Brazil, Mexico, and China

Report coverage        

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments covered in the report

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2012 to 2022. For the purpose of this study, Grand View Research has segmented the global malaria diagnostics market report on the basis of technology, and region:

  • Technology Outlook (Revenue, USD Million, 2012 - 2022)

    • Microscopy

    • Rapid Diagnostic Tests

    • Others

  • Regional Outlook (Revenue, USD Million, 2012 - 2022)

    • Africa

      • South Africa

      • Nigeria

    • South-East Asia

      • India

    • Eastern Mediterranean

      • Saudi Arabia

    • Europe

      • Turkey

    • America

      • Brazil

      • Mexico

    • Western Pacific

      • China

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $7,950
BI Library Access - $9,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified